The registration, importation and distribution of all heartburn medication containing ranitidine has been suspended in the UAE.
According to the Ministry of Health and Prevention (MoHAP), a circular was issued to health facilities and practitioners informing them about the move.
The decision is based on the recommendations of the US Food and Drug Administration (FDA) and other regulatory bodies regarding a possible contamination of the medicine with an impurity which is classified as potentially carcinogenic.
The Ministry says those wishing to stop taking medicine with ranitidine should consult a healthcare professional for a replacement.
UAE, UK ministers discuss regional stability, bilateral ties
H.H. Sheikh Hamdan reviews operations, developments at Jebel Ali Port
Drugs hidden inside passenger’s body seized at Abu Dhabi Airport
UAE President, Montenegro PM discuss stronger bilateral cooperation
Fujairah says pipeline work triggered fire in petroleum industries area
Yas Island announced as location for Sphere Abu Dhabi project
Warning issued on dangers of sudden road stops after 1 dead, 19 injured
UAE says reports of Israeli PM Netanyahu's visit 'entirely unfounded'
UAE launches platform to help Emiratis choose 'right academic, career paths'
Dubai Customs foils attempt to smuggle endangered bears through airport
UAE, Syria Presidents discuss cooperation and regional developments
UAE President, Qatari Emir discuss ties and regional developments
UAE reinforces anti-money laundering standards in gold sector
Eid Al Adha holidays confirmed for Dubai Government entities
UAE President holds talks with US, Saudi Arabia leaders
Dubai's Parkin begins roll out of AI curb-side parking cameras
UAE reviews AI readiness across federal government
From Sweden to India, 10 nurses shortlisted for $250,000 global award
UAE, Kuwaiti Foreign Ministers discuss foiled infiltration operation by Iran's IRGC
UAE adds 16 individuals, 5 entities to terror list over Hezbollah links
